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The anesthesiological approach to rare diseases (RD) is
particularly challenging for providers. The high number
of pathologies and the scarcity of clinical reports
impedes to arrange a pool of dedicated anaesthesiolo-
gists. When facing RD, the risk linked to unaware mal-
practice is often due to lack of experience, mostly of
urgent/emergent procedures [1].
It is probably impossible to know all relevant aspects
in more than 8000 pathologies that affect approximately
6-8% of the population [2]. In order to reduce anesthe-
siological risk, it is mandatory to develop a systematic
approach.
1. First and foremost, let’s take advantage of previous
experiences. There are specific search engines available
online [http://www.orphananesthesia.eu; http://www.
orpha.net; http://www.omim.org
], which briefly summarize the knowledge about RDs.
Furthermore, for major pathologies there are national
and international main centres providing medical
counselling.
As a whole, we can attribute the anesthesiological risk
to four cohorts.
Careful evaluation should be dedicated to current sys-
temic impairments [3]. Children affected by cystic fibro-
sis need special care, due to specific organ failure. In
some types of porphyrias it is mandatory to achieve a
good control on pain, anxiety and nausea, because stress-
ful events could trigger a severe crisis.
In some cases, pathological processes can affect phar-
macodynamics causing abnormal responses to drugs,
such as the enhancement of curarization in myasthenic
patients, or a real adverse event like the risk of Malignant
Hyperthermia associated with Wolf-Hirschhorn Syn-
drome [4] or Arthrogryposis.
A third item to investigate is whether anesthetic drugs
can interact with specific concurrent therapies. There
are some suggestions that the previous therapy with
eculizumab, a new monoclonal antibody for the treat-
ment of paroxysmal nocturnal haemoglobinuria, predis-
poses to haemolytic crisis in occurrence of general
anesthesia.
The last cohort, but the most frequent, concerns the dif-
ficult management of airways. Craniofacial malformations
can represent a very big deal due to mandible hypoplasia
such as Pierre Robin syndrome or Treacher-Collins
syndrome; hemifacial microsomia such as Goldenhar syn-
drome; midface hypoplasia as Apert syndrome [5], Crou-
zon syndrome, Pfeiffer syndrome and macroglossia such
as Hurler’s syndrome, Hunter’s syndrome, or weakness of
atlanto-occipital joint such as Downs syndrome, Ehlers-
Danlos syndrome type IV or osteogenesis imperfecta.
Tracheal intubation should indeed be avoided in syn-
dromes as epidermolysis bullosa to prevent severe tracheal
lesions.
In conclusion, besides patients with a clear diagnosis,
sometimes a simple pathology can hide unknown RDs
[6]. For this reason the pre-anesthesiological evaluation
is crucial, more than ever in syndromic children, to
assess the risk before undergoing general anesthesia or
sedation. This allows the best strategy to work safely to
be put in place and to improve outcome.
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